Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $2.6 Million - $3.67 Million
-44,241 Reduced 90.72%
4,527 $363,000
Q1 2024

May 15, 2024

SELL
$51.07 - $68.26 $651,142 - $870,315
-12,750 Reduced 20.73%
48,768 $3.04 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $777,288 - $1.09 Million
13,980 Added 29.41%
61,518 $3.81 Million
Q3 2023

Nov 14, 2023

BUY
$60.27 - $90.75 $2.48 Million - $3.73 Million
41,117 Added 640.35%
47,538 $3.3 Million
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $25,135 - $30,393
305 Added 4.99%
6,421 $538,000
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $73,980 - $128,350
1,549 Added 33.92%
6,116 $504,000
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $222,686 - $354,718
4,567 New
4,567 $232,000
Q2 2022

Aug 15, 2022

SELL
$55.54 - $72.65 $1.11 Million - $1.46 Million
-20,038 Reduced 85.56%
3,382 $223,000
Q1 2022

May 16, 2022

BUY
$24.28 - $56.64 $568,637 - $1.33 Million
23,420 New
23,420 $1.3 Million
Q3 2020

Nov 16, 2020

SELL
$11.98 - $16.34 $39,641 - $54,069
-3,309 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$9.11 - $20.05 $24,560 - $54,054
2,696 Added 439.8%
3,309 $42,000
Q4 2019

Feb 14, 2020

BUY
$18.47 - $24.03 $11,322 - $14,730
613 New
613 $13,000
Q2 2019

Aug 14, 2019

SELL
$23.33 - $28.3 $15,607 - $18,932
-669 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$14.93 - $25.1 $2,134 - $3,589
143 Added 27.19%
669 $16,000
Q4 2018

Feb 14, 2019

SELL
$12.68 - $19.01 $19,400 - $29,085
-1,530 Reduced 74.42%
526 $8,000
Q3 2018

Nov 14, 2018

BUY
$13.1 - $16.35 $26,933 - $33,615
2,056 New
2,056 $31,000
Q2 2018

Aug 14, 2018

SELL
$13.65 - $18.7 $384,861 - $527,246
-28,195 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$14.85 - $24.3 $40,659 - $66,533
2,738 Added 10.76%
28,195 $448,000
Q4 2017

Feb 14, 2018

BUY
$17.4 - $23.4 $63,057 - $84,801
3,624 Added 16.6%
25,457 $521,000
Q3 2017

Nov 14, 2017

BUY
$15.5 - $19.15 $338,411 - $418,101
21,833
21,833 $389,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.7B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.